1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Qin, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be published 0353 Structural, dynamics, and RNA binding comparison between RBM10-RRM2 domain and its lung cancer related mutation. 10.2210/pdb5zsy/pdb pdb_00005zsy 9577.053 RNA-binding protein 10 RBM10 RRM2 domain 1 man polymer G patch domain-containing protein 9,RNA-binding motif protein 10,RNA-binding protein S1-1,S1-1 no no GHMDTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIEAAQLLQILQALHPPLTIDGKTI NVEFAKGS GHMDTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIEAAQLLQILQALHPPLTIDGKTI NVEFAKGS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Human sample 1 88 RBM10, DXS8237E, GPATC9, GPATCH9, KIAA0122 9606 Homo sapiens 562 Escherichia coli Biological sequence database_2 pdbx_database_status pdbx_nmr_spectrometer repository Initial release Data collection Database references Other 1 0 2019-06-12 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_spectrometer.model RBM10-RRM2 domain and its lung cancer related mutant N PDBJ Y PDBJ 2018-04-30 REL REL REL REL Sequence of the protein is based on isoform 4 of database P98175 (RBM10_HUMAN). structures with the lowest energy 40 20 isotropic 1 4D APSY-HACANH isotropic 1 5D APSY-CBCACONH isotropic 1 5D APSY-HACACONH isotropic 2 3D 1H-15N NOESY isotropic 2 3D 1H-13C NOESY aliphatic isotropic 2 3D 1H-13C NOESY aromatic 1.0 mM [U-100% 13C; U-100% 15N] 20mM sodium Phosphate, 50mM sodium chloride 20mM sodium Phosphate, 50mM sodium chloride mM condition_1 6.5 pH 1 Pa 298 K molecular dynamics 1 lowest energy 1.0 mM [U-100% 13C; U-100% 15N] RBM10 RRM2[V354del], 90% H2O/10% D2O 15N_13C_sample 90% H2O/10% D2O solution Volk, J.; Herrmann, T.; Fiorito, F.; Wuthrich, K. chemical shift assignment UNIO-ASCAN Guntert, Mumenthaler and Wuthrich structure calculation CYANA Luginbuhl, Guntert, Billeter and Wuthrich refinement OPAL 600 Bruker AVANCE 800 Bruker AVANCE GLY 1 n 1 GLY 1 A HIS 2 n 2 HIS 2 A MET 3 n 3 MET 3 A ASP 4 n 4 ASP 4 A THR 5 n 5 THR 5 A ILE 6 n 6 ILE 6 A ILE 7 n 7 ILE 7 A LEU 8 n 8 LEU 8 A ARG 9 n 9 ARG 9 A ASN 10 n 10 ASN 10 A LEU 11 n 11 LEU 11 A ASN 12 n 12 ASN 12 A PRO 13 n 13 PRO 13 A HIS 14 n 14 HIS 14 A SER 15 n 15 SER 15 A THR 16 n 16 THR 16 A MET 17 n 17 MET 17 A ASP 18 n 18 ASP 18 A SER 19 n 19 SER 19 A ILE 20 n 20 ILE 20 A LEU 21 n 21 LEU 21 A GLY 22 n 22 GLY 22 A ALA 23 n 23 ALA 23 A LEU 24 n 24 LEU 24 A ALA 25 n 25 ALA 25 A PRO 26 n 26 PRO 26 A TYR 27 n 27 TYR 27 A ALA 28 n 28 ALA 28 A VAL 29 n 29 VAL 29 A LEU 30 n 30 LEU 30 A SER 31 n 31 SER 31 A SER 32 n 32 SER 32 A SER 33 n 33 SER 33 A ASN 34 n 34 ASN 34 A VAL 35 n 35 VAL 35 A ARG 36 n 36 ARG 36 A VAL 37 n 37 VAL 37 A ILE 38 n 38 ILE 38 A LYS 39 n 39 LYS 39 A ASP 40 n 40 ASP 40 A LYS 41 n 41 LYS 41 A GLN 42 n 42 GLN 42 A THR 43 n 43 THR 43 A GLN 44 n 44 GLN 44 A LEU 45 n 45 LEU 45 A ASN 46 n 46 ASN 46 A ARG 47 n 47 ARG 47 A GLY 48 n 48 GLY 48 A PHE 49 n 49 PHE 49 A ALA 50 n 50 ALA 50 A PHE 51 n 51 PHE 51 A ILE 52 n 52 ILE 52 A GLN 53 n 53 GLN 53 A LEU 54 n 54 LEU 54 A SER 55 n 55 SER 55 A THR 56 n 56 THR 56 A ILE 57 n 57 ILE 57 A GLU 58 n 58 GLU 58 A ALA 59 n 59 ALA 59 A ALA 60 n 60 ALA 60 A GLN 61 n 61 GLN 61 A LEU 62 n 62 LEU 62 A LEU 63 n 63 LEU 63 A GLN 64 n 64 GLN 64 A ILE 65 n 65 ILE 65 A LEU 66 n 66 LEU 66 A GLN 67 n 67 GLN 67 A ALA 68 n 68 ALA 68 A LEU 69 n 69 LEU 69 A HIS 70 n 70 HIS 70 A PRO 71 n 71 PRO 71 A PRO 72 n 72 PRO 72 A LEU 73 n 73 LEU 73 A THR 74 n 74 THR 74 A ILE 75 n 75 ILE 75 A ASP 76 n 76 ASP 76 A GLY 77 n 77 GLY 77 A LYS 78 n 78 LYS 78 A THR 79 n 79 THR 79 A ILE 80 n 80 ILE 80 A ASN 81 n 81 ASN 81 A VAL 82 n 82 VAL 82 A GLU 83 n 83 GLU 83 A PHE 84 n 84 PHE 84 A ALA 85 n 85 ALA 85 A LYS 86 n 86 LYS 86 A GLY 87 n 87 GLY 87 A SER 88 n 88 SER 88 A author_defined_assembly 1 monomeric gel filtration 0 0 5850 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N ARG 36 A N ARG 36 A O PHE 51 A O PHE 51 A O ALA 50 A O ALA 50 A N LEU 8 A N LEU 8 A N ILE 7 A N ILE 7 A O GLU 83 A O GLU 83 17 A A HG OE1 SER GLU 55 58 1.56 2 A A ASP THR 4 5 147.67 10 A A GLY SER 87 88 145.43 15 A A SER THR 15 16 144.19 20 A A HIS MET 2 3 148.68 1 A TYR 27 0.083 SIDE CHAIN 2 A ARG 9 0.089 SIDE CHAIN 7 A TYR 27 0.094 SIDE CHAIN 7 A ARG 36 0.090 SIDE CHAIN 9 A TYR 27 0.078 SIDE CHAIN 10 A ARG 9 0.107 SIDE CHAIN 14 A TYR 27 0.077 SIDE CHAIN 16 A ASP 76 0.070 SIDE CHAIN 17 A ARG 36 0.077 SIDE CHAIN 19 A ARG 47 0.078 SIDE CHAIN 1 A ASP 4 66.03 94.06 1 A SER 31 -84.90 -85.56 1 A SER 32 -170.26 -50.63 1 A HIS 70 -46.45 152.61 1 A ASP 76 -166.72 -22.80 1 A ALA 85 -117.71 70.79 2 A MET 3 74.17 30.35 2 A THR 16 -124.85 -164.40 2 A ALA 23 -141.30 -25.40 2 A ALA 25 -116.48 53.85 2 A SER 31 -85.45 37.24 2 A SER 32 60.19 -64.01 2 A ASP 40 -63.69 -174.77 2 A GLN 44 65.34 -13.41 2 A LEU 45 -65.39 -179.08 2 A ALA 68 -153.57 -30.19 2 A ASP 76 -170.63 24.32 3 A HIS 2 -154.79 -64.53 3 A ASP 4 71.65 86.31 3 A LEU 24 -102.56 42.48 3 A ALA 25 -119.68 54.14 3 A TYR 27 -135.46 -59.36 3 A ASP 76 174.67 30.25 4 A HIS 2 -125.24 -61.54 4 A ASP 4 46.44 83.54 4 A THR 16 -122.66 -86.98 4 A MET 17 -163.62 -37.30 4 A ALA 23 -141.44 12.68 4 A TYR 27 -137.37 -66.86 4 A SER 32 58.21 -81.20 4 A ALA 68 -144.16 13.90 4 A ASP 76 -168.67 32.94 4 A LYS 86 -101.13 69.92 5 A MET 3 -73.46 23.24 5 A ASP 4 -173.29 84.72 5 A GLN 44 57.38 13.45 5 A ASP 76 -168.54 37.07 5 A LYS 86 -61.56 93.19 6 A ASP 4 59.53 85.97 6 A TYR 27 -122.09 -51.99 6 A SER 32 61.65 -49.43 6 A ARG 36 -66.46 86.58 6 A GLN 42 -127.75 -51.43 6 A ALA 68 -154.38 -14.43 6 A LEU 69 -68.47 -162.70 6 A ASP 76 -167.70 24.65 7 A ASP 4 43.88 84.08 7 A THR 16 -123.56 -57.82 7 A MET 17 -157.71 -56.38 7 A ILE 20 -137.38 -48.69 7 A ALA 23 -139.95 -40.32 7 A ALA 25 -114.68 61.90 7 A TYR 27 -124.15 -65.01 7 A SER 32 73.07 -56.40 7 A ASP 40 -44.39 -86.77 7 A LYS 41 172.41 -55.77 7 A GLN 44 56.30 14.52 7 A ALA 68 -139.98 -30.70 7 A ASP 76 -174.53 34.52 8 A ASP 4 43.03 84.03 8 A THR 16 -107.23 -86.13 8 A MET 17 -161.13 -68.48 8 A SER 31 -74.05 36.47 8 A SER 32 59.97 -73.72 8 A LYS 41 74.55 -56.99 8 A GLN 44 70.92 -15.15 8 A ALA 68 -136.06 -37.82 8 A HIS 70 -48.26 160.73 8 A ASP 76 -174.87 34.67 8 A ALA 85 -102.34 78.73 9 A HIS 2 -141.77 -60.04 9 A MET 3 53.42 -164.29 9 A ASP 4 50.97 89.56 9 A THR 16 -128.55 -85.87 9 A MET 17 -156.68 -50.74 9 A TYR 27 -142.06 -24.04 9 A SER 32 58.18 -45.80 9 A GLN 44 70.49 -12.73 9 A ASP 76 173.84 17.58 10 A MET 3 -69.52 -171.84 10 A THR 16 -129.44 -85.83 10 A MET 17 -158.28 -66.65 10 A LEU 24 -86.53 30.67 10 A ALA 25 -114.67 53.47 10 A SER 31 -77.66 35.50 10 A SER 32 63.63 -70.64 10 A GLN 42 -92.72 -62.30 10 A GLN 44 72.72 -13.77 10 A LEU 45 -61.38 -179.07 10 A ALA 68 -131.23 -33.01 10 A LEU 69 -58.84 175.77 10 A ASP 76 -171.21 32.84 11 A MET 3 75.08 65.98 11 A THR 16 -129.20 -86.03 11 A MET 17 -159.45 -40.48 11 A ALA 23 -124.38 -64.63 11 A LEU 24 -88.77 45.53 11 A LYS 41 75.14 -67.98 11 A ALA 68 -147.71 -21.39 11 A ASP 76 -164.58 29.07 11 A LYS 86 -68.48 97.33 12 A HIS 2 48.35 -171.82 12 A ASP 4 45.79 94.24 12 A THR 16 -135.83 -39.92 12 A MET 17 -175.06 -60.08 12 A ASP 40 -68.67 -175.48 12 A ALA 68 -133.51 -43.32 12 A LEU 69 -77.08 -168.89 12 A ASP 76 178.19 42.62 12 A LYS 86 -71.63 42.09 13 A HIS 2 -164.00 -45.66 13 A ASP 4 61.41 90.91 13 A ASN 10 74.18 39.57 13 A ASN 12 -49.53 154.60 13 A THR 16 60.13 -164.86 13 A ALA 23 -136.55 -37.85 13 A LEU 24 -95.14 31.31 13 A GLN 44 68.22 -14.31 13 A ALA 68 -142.24 13.95 13 A HIS 70 55.61 167.22 13 A ASP 76 -163.70 31.04 14 A HIS 2 74.99 -58.70 14 A MET 3 50.94 -163.76 14 A THR 16 -124.63 -164.24 14 A ALA 23 -144.51 -21.62 14 A ALA 25 -119.94 52.42 14 A LYS 41 73.84 -20.93 14 A GLN 44 58.73 -13.73 14 A ASP 76 -173.01 31.07 14 A ALA 85 -112.72 71.12 15 A ASP 4 43.38 83.50 15 A ILE 20 -132.32 -34.73 15 A ALA 23 -150.65 -40.49 15 A ALA 25 -114.54 53.67 15 A TYR 27 -124.41 -79.60 15 A SER 31 -79.63 23.45 15 A SER 32 55.29 -60.41 15 A GLN 42 -124.08 -50.56 15 A GLN 44 71.74 -12.66 15 A ASN 46 -69.63 -165.73 15 A ALA 68 -131.40 -34.42 15 A LEU 69 -75.84 -166.77 15 A ILE 75 -145.44 13.98 15 A ASP 76 -166.70 18.58 16 A ASP 4 74.73 98.32 16 A THR 16 -125.64 -74.17 16 A MET 17 -153.80 -48.00 16 A ALA 23 -143.16 -34.20 16 A ALA 25 -115.71 53.47 16 A GLN 42 -130.35 -42.29 16 A GLN 44 73.11 -13.73 16 A LEU 54 -135.89 -154.86 16 A ASP 76 -173.94 28.00 17 A ASP 4 75.25 94.53 17 A ALA 23 -142.60 12.98 17 A ALA 25 -114.95 52.66 17 A TYR 27 -134.59 -58.12 17 A SER 31 -90.18 33.00 17 A SER 32 68.61 -61.95 17 A GLN 44 57.32 14.77 17 A ALA 68 -141.65 14.50 17 A ASP 76 -171.68 41.07 18 A MET 3 -151.37 82.88 18 A ASP 4 174.78 109.00 18 A THR 16 -147.29 -74.69 18 A MET 17 -160.67 -57.22 18 A ILE 20 -135.11 -47.09 18 A SER 32 174.92 -46.59 18 A HIS 70 49.75 166.93 18 A ASP 76 -166.82 31.21 19 A HIS 2 -130.22 -72.47 19 A MET 3 -167.24 93.07 19 A ASP 4 42.63 83.23 19 A ALA 23 -149.28 -34.98 19 A ALA 25 -116.87 57.06 19 A GLN 44 66.14 -13.30 19 A LEU 45 -65.11 -167.53 19 A ASP 76 -169.32 33.82 20 A HIS 2 55.05 170.81 20 A ASP 4 57.99 84.68 20 A THR 16 44.45 -164.59 20 A GLN 44 72.32 -13.06 20 A ALA 68 -144.06 14.47 20 A HIS 70 -46.66 158.47 20 A ASP 76 -161.39 37.74 N RBM10-RRM2 domain and its lung cancer related mutant 1 N N A MET 17 A MET 17 HELX_P A GLY 22 A GLY 22 1 AA1 6 A SER 55 A SER 55 HELX_P A GLN 67 A GLN 67 1 AA2 13 RNA BINDING PROTEIN classical folding and binding mode, RNA BINDING PROTEIN RBM10_HUMAN UNP 1 223 P98175 P98175-4 DTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIEAAQLLQILQALHPPLTIDGKTINVE FAKGS 223 307 5ZSY 4 88 P98175 A 1 4 88 1 expression tag GLY 1 5ZSY A P98175 UNP 1 1 expression tag HIS 2 5ZSY A P98175 UNP 2 1 expression tag MET 3 5ZSY A P98175 UNP 3 4 anti-parallel anti-parallel anti-parallel A VAL 35 A VAL 35 A ARG 36 A ARG 36 A ALA 50 A ALA 50 A ILE 52 A ILE 52 A ILE 6 A ILE 6 A ARG 9 A ARG 9 A ASN 81 A ASN 81 A PHE 84 A PHE 84